Industry News
Medical Marketing & Media
PRWeek
Fierce Pharma
Reuters
The Pink Sheet
- TREAT Act Wants Accelerated Approval Change, But Uses Existing Language
- Innovative Drug Development: Kalydeco Provides A Paradigm, FDA’s Spielberg Says
- GPhA’s Neas Preaches Vigilance Against Reopening Hatch-Waxman Act
- FDA’s ANDA Approvals
- GSK Says R&D Productivity Up, But Story Is About Culture, Not Numbers
New York Times
Pharma Marketing News
Pharmaceutical Executive